LU83713A1 - Derives de la pyrimidine,leur procede de preparation et les compositions pharmaceutiques les contenant - Google Patents

Derives de la pyrimidine,leur procede de preparation et les compositions pharmaceutiques les contenant Download PDF

Info

Publication number
LU83713A1
LU83713A1 LU83713A LU83713A LU83713A1 LU 83713 A1 LU83713 A1 LU 83713A1 LU 83713 A LU83713 A LU 83713A LU 83713 A LU83713 A LU 83713A LU 83713 A1 LU83713 A1 LU 83713A1
Authority
LU
Luxembourg
Prior art keywords
pyrimidine
phenyl
diamino
methyl
chloro
Prior art date
Application number
LU83713A
Other languages
English (en)
French (fr)
Inventor
Robert B Walker
Jack Hill
Dennis Warburton
William B Sharp
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of LU83713A1 publication Critical patent/LU83713A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
LU83713A 1980-10-27 1981-10-26 Derives de la pyrimidine,leur procede de preparation et les compositions pharmaceutiques les contenant LU83713A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8034572 1980-10-27
GB8034572 1980-10-27

Publications (1)

Publication Number Publication Date
LU83713A1 true LU83713A1 (fr) 1982-05-07

Family

ID=10516909

Family Applications (1)

Application Number Title Priority Date Filing Date
LU83713A LU83713A1 (fr) 1980-10-27 1981-10-26 Derives de la pyrimidine,leur procede de preparation et les compositions pharmaceutiques les contenant

Country Status (23)

Country Link
US (1) US4374136A (da)
JP (1) JPS5799573A (da)
KR (1) KR830007580A (da)
AU (1) AU547334B2 (da)
BE (1) BE890874A (da)
CH (1) CH650776A5 (da)
DE (1) DE3142559A1 (da)
DK (1) DK146067C (da)
EG (1) EG15900A (da)
FR (1) FR2492821A1 (da)
GR (1) GR75366B (da)
IE (1) IE51670B1 (da)
IL (1) IL64123A (da)
IT (1) IT1139562B (da)
KE (1) KE3690A (da)
LU (1) LU83713A1 (da)
MA (1) MA19313A1 (da)
MY (1) MY8500556A (da)
NL (1) NL8104766A (da)
OA (1) OA07362A (da)
PH (1) PH17779A (da)
ZA (1) ZA817298B (da)
ZW (1) ZW25681A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4673677A (en) * 1983-10-03 1987-06-16 Pfizer Inc. Method for treatment of gastrointestinal disorders
CA2095518A1 (en) * 1990-11-14 1992-05-15 Jeffrey M. Blaney Specific inhibition of dihydrofolate reductase and compounds therefor
AU2001280445A1 (en) * 2000-06-23 2002-01-08 Vanderbilt University Novel chain-breaking antioxidants
US8367669B2 (en) * 2005-06-15 2013-02-05 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation
US9133212B1 (en) 2005-06-15 2015-09-15 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation
JP5603775B2 (ja) 2007-10-08 2014-10-08 エムエムヴィ メディスィンズ フォー マラリア ヴェンチュアー 柔軟な側鎖を有する抗マラリア化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1546937A (en) * 1976-07-29 1979-05-31 Beecham Group Ltd 2,4-diaminopyrimidine derivatives

Also Published As

Publication number Publication date
IE51670B1 (en) 1987-02-04
FR2492821A1 (fr) 1982-04-30
EG15900A (en) 1987-10-30
BE890874A (fr) 1982-04-26
DE3142559A1 (de) 1982-09-02
KE3690A (en) 1987-02-20
ZA817298B (en) 1982-09-29
NL8104766A (nl) 1982-05-17
GR75366B (da) 1984-07-13
MY8500556A (en) 1985-12-31
IE812498L (en) 1982-04-27
IT8124721A0 (it) 1981-10-27
AU7674581A (en) 1982-05-06
DK146067C (da) 1983-11-14
JPS5799573A (en) 1982-06-21
KR830007580A (ko) 1983-11-04
AU547334B2 (en) 1985-10-17
CH650776A5 (fr) 1985-08-15
MA19313A1 (fr) 1982-07-01
OA07362A (fr) 1984-06-30
IL64123A0 (en) 1982-01-31
DK146067B (da) 1983-06-20
US4374136A (en) 1983-02-15
FR2492821B1 (da) 1985-02-01
PH17779A (en) 1984-12-11
DK471181A (da) 1982-04-28
ZW25681A1 (en) 1982-01-13
IT1139562B (it) 1986-09-24
IL64123A (en) 1986-02-28

Similar Documents

Publication Publication Date Title
EP0110781B1 (fr) (Amino-2 éthyl)-6 benzoxazolinones substituées, leur préparation et une composition pharmaceutique les contenant
EP0015038B1 (fr) Composition pharmaceutique comprenant un dérivé de diphénylhydantoine, dérivés mis en oeuvre et leur préparation
FR2511679A1 (fr) Nouvelles imidazotetrazinones, leur preparation et les medicaments qui les contiennent
FR2498931A1 (fr) Medicament constitue par l'acide ethyl-1 fluoro-6 piperazinyl-7 oxo-4 dihydro-1,4 quinoleine-3 carboxylique et ses sels d'addition d'acides non toxiques pharmaceutiquement acceptables
LU83713A1 (fr) Derives de la pyrimidine,leur procede de preparation et les compositions pharmaceutiques les contenant
FR2702150A1 (fr) Application de dérivés de 2H-1,2-4-benzothiadiazine-3(4H)-one-1,1-dioxyde comme antagonistes non compétitifs du récepteur NMDA.
EP0113330B1 (fr) Composés énamides acylés, compositions pharmaceutiques les contenant, utilisation de ces composés et procédé de préparation de ces composés
BE897068A (fr) Nouveau derive de la pyrazolo [1,5-a] pyridine sa preparation et les compositions pharmaceutiques qui les contiennent
EP0183577B1 (fr) Dérivés du thiadiazole actifs sur le système nerveux central, procédé d'obtension et compositions pharmaceutiques les contenant
FR2612188A1 (fr) 3-(2-haloalkyl)-1,4-oxathiines et 2-(2-haloalkyl)-1,4-dithiines, compositions pharmaceutiques les contenant et procede pour le traitement de la leucemie et des tumeurs les utilisant
EP0347305B1 (fr) [(Aryl-4-pipérazinyl-1)-2 éthoxy]-3 p-cymène, les dérivés ortho, méta, para monosubstitués ou disubstitués sur le noyau phényle dudit produit, le procédé de préparation desdits dérivés, et les médicaments contenant lesdits composés comme principe actif
EP0036357B1 (fr) Dérivés cétoniques de diaryl 5-6 triazines 1-2-4 antalgiques et antiagrégants utilisables dans le traitement de fond des migraines
OA13294A (fr) Molécules duales contenant un dérivé peroxydique, leur synthèse et leurs applications thérapeutiques.
FR2477151A1 (fr) Derives de la piperazine, leur preparation et leurs utilisations en medecine
CH629194A5 (fr) Amino aryl triazines-1,2,4 utilisables dans le traitement d'algies diverses.
FR2475543A1 (fr) Derives benzylideniques, leur preparation et leur application en therapeutique
EP0034521B1 (fr) Médicament analgésique contenant de la 1-(3'benzofuryl)-4-benzylpipérazine et son procédé de préparation
CA1068270A (fr) Diamino-2,4-bromo-5 chloro-6 pyrimidines utilisables comme medicaments et procede pour leur preparation
LU82672A1 (fr) Acides 2-amino-3-(alkylthiobenzoyl)-phenylacetiques et derives,et leur utilisation comme anti-inflammatoires,analgesiques,et inhibant l'agglomeration des plaquettes sanguines
FR2491471A1 (fr) Benzoxazolinones substituees, leur preparation et leur application en therapeutique
EP0120741B1 (fr) Nouveaux médicaments dérivés de la chloro-4 dithiole-1,2 one-3 et les compositions médicinales qui les contiennent
LU81892A1 (fr) Nouveaux dithiocarbamates, leur preparation et les medicaments qui les contiennent
FR2706463A1 (fr) Nouveaux dérivés d'aziridino spirodiazaalkylcyclotriphosphazènes substitués leur procédé de préparation et leur utilisation en tant que médicament.
FR2487196A1 (fr) Composition pharmaceutique produisant des effets diuretiques, hypotenseurs et anti-oedemateux a base de derive quinoleinique
FR2503142A1 (en) N-Substd. 4-aminoethoxy-2-methyl-5-isopropyl-phenol derivs. - useful as alpha blockers and platelet aggregation inhibitors